Sort
27,075 grants matching “cholesterol”
Biochemical Analysis and Engineering of Lovastatin Polyketide Synthase
$219,359Yi Tang · University Of California Los Angeles · R21 · FY2008 · GM
Development and Use of Network Infrastructure for High-Throughput GWA Studies
$219,307Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2008 · HG
Marine Fatty Acids as New Antifungal, Antimycobacterial, and Topo-l Agents
$219,175Nestor Manuel Carballeira · University Of Puerto Rico Rio Piedras · SC1 · FY2008 · GM
Roles of MLL histone methyalses in estrogen mediated regulation of HDLR-SRB1
$219,000Subhrangsu S Mandal · University Of Texas Arlington · R15 · FY2010 · HL
Development of antivirals for newly emerging pathogens Ebola and Marburg.
$218,900Matteo Porotto · Weill Medical Coll Of Cornell Univ · R21 · FY2012 · AI
Tracking Cellular Cholesterol Efflux in Real Time
$218,900Case Western Reserve University · R21 · FY2004 · EB
SR NIACIN VERSUS IHN: LIPID-ALTERING AND METABOLIC EFFECTS
$218,827Joseph Keenan · University Of Minnesota · M01 · FY2007 · RR
Interruption of squalene epoxidase and DNA damage response in cancer therapy
$218,790Junran Zhang · Ohio State University · R21 · FY2020 · CA
PROJECT C
$218,768Ronny Korstanje · Jackson Laboratory · P50 · FY2013 · GM
Single-cell transcriptional atlas of Giardia encystation
$218,767Alexander Richard Paredez · University Of Washington · R21 · FY2025 · AI
Development of a Real Time Cellular Tool to Monitor a Previously Untraceable Lipid
$218,750Robert Virgil Stahelin · Purdue University · R21 · FY2018 · GM
Investigating mechanisms of oxidized phospholipid-mediated dysregulation of regulatory T cells in atherosclerosis
$218,750Amy S Major · Vanderbilt University Medical Center · R21 · FY2024 · AI
New Pathway Limits Cellular Cholesterol Content
$218,738University Of California San Francisco · R01 · FY2003 · HL
The Yeast Ergosterol Pathway
$218,595Martin Bard · Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2006 · GM
Solid-state NMR studies of antimicrobial peptides
$218,528Mei Hong · Iowa State University · R01 · FY2006 · GM
Role of lipid rafts and phosphoinositides in E. histolytica virulence
$218,518Lesly A Temesvari · Clemson University · R01 · FY2009 · AI
General Anesthetic Sites on Ligand-Gated Ion Channels
$218,494Massachusetts General Hospital · P01 · FY2001 · GM
Research Training in Heart, Lung, Blood & Sleep Diseases
$218,473Claire M Doerschuk · Case Western Reserve University · T35 · FY2007 · HL
Research Training in Heart, Lung, Blood & Sleep Diseases
$218,473Susan S Redline · Case Western Reserve University · T35 · FY2008 · HL
Mass Spectrometry Analysis of Lipid-Protein Interactions and Structural Heterogeneity in the Anthrax Toxin Pore
$218,430James Stephen Prell · University Of Oregon · R21 · FY2018 · AI
COBRE: U NEL: CORE A: METABOLOMICS: PROTEOMICS, MICROSCOPY, GENOMICS, CYTOMETRY
$218,415Nandakumar Madayiputhiya · University Of Nebraska Lincoln · P20 · FY2009 · RR
Hepatic Wnt/LRP6 Regulation of Plasma Lipids
$218,408Arya Mani · Yale University · R01 · FY2017 · HL
Measurement of arterial mechanical properties during plaque progression
$218,400Seemantini K Nadkarni · Massachusetts General Hospital · R21 · FY2008 · HL
Targeting Hexokinase II in Chemotherapy
$218,400John G Pastorino · Univ Of Med/Dent Nj-Sch Osteopathic Med · R01 · FY2009 · CA
Targeting Hexokinase II in Chemotherapy
$218,400John G Pastorino · Univ Of Med/Dent Nj-Sch Osteopathic Med · R01 · FY2008 · CA